Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis

Astragaloside IV (AS-IV), the essential active component of astragalus, possesses diverse biological activities that have beneficial effects against cardiovascular disease. Here, we conducted a preclinical systematic review of 15 studies including 577 animals to establish the efficacy and potential...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Zhuang Zhuang, Zi-Hao Wang, Li-Hui Deng, Qun Zheng, Guo-Qing Zheng, Yan Wang
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2019-11-01
Schriftenreihe:	Frontiers in Pharmacology
Schlagworte:	Astragaloside IV myocarditis efficacy mechanisms meta-analysis
Online-Zugang:	https://www.frontiersin.org/article/10.3389/fphar.2019.01388/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!